REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,685,528 | +199.9% | 205,402 | +189.8% | 0.00% | – |
| Q2 2023 | $1,895,666 | +44.6% | 70,866 | +17.1% | 0.00% | – |
| Q1 2023 | $1,310,820 | +106.9% | 60,518 | +127.6% | 0.00% | – |
| Q4 2022 | $633,445 | +19.5% | 26,593 | -1.2% | 0.00% | – |
| Q3 2022 | $530,000 | +17.8% | 26,922 | +16.6% | 0.00% | – |
| Q2 2022 | $450,000 | -23.2% | 23,085 | +0.6% | 0.00% | – |
| Q1 2022 | $586,000 | +2.3% | 22,939 | +0.9% | 0.00% | – |
| Q4 2021 | $573,000 | +5.5% | 22,733 | +15.1% | 0.00% | – |
| Q3 2021 | $543,000 | -27.6% | 19,749 | -16.4% | 0.00% | – |
| Q2 2021 | $750,000 | +80.7% | 23,622 | +160.9% | 0.00% | – |
| Q1 2021 | $415,000 | -38.9% | 9,054 | -47.2% | 0.00% | – |
| Q4 2020 | $679,000 | +30.3% | 17,153 | +4.1% | 0.00% | – |
| Q2 2020 | $521,000 | – | 16,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $104,824,198 | 43.76% |
| Column Group LLC | 4,577,840 | $99,156,014 | 35.85% |
| Mass General Brigham, Inc | 338,191 | $7,325 | 5.71% |
| Boxer Capital, LLC | 4,684,264 | $101,461 | 4.98% |
| BVF INC/IL | 4,955,588 | $107,338,036 | 3.92% |
| DAFNA Capital Management LLC | 575,785 | $12,471,503 | 3.74% |
| EcoR1 Capital, LLC | 5,352,183 | $115,928,284 | 3.73% |
| Casdin Capital, LLC | 1,810,000 | $39,204,600 | 3.23% |
| Artal Group S.A. | 2,070,988 | $44,858 | 2.66% |
| Integral Health Asset Management, LLC | 345,000 | $7,472,700 | 1.50% |